Clinical Trial Update: Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the efficacy and safety of LP-003 in adults with moderate-to-severe seasonal allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• LP-003

Snippet

Sponsor: Longbio Pharma | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED